top of page


Let us
help you to
help patients

We partner with leading clinicians, researchers and providers to help cancer patients everywhere while improving your practice.


Join our mission to help cancer patients live better, not just longer

Our team at Luminate is developing new technology to improve quality of life for cancer patients. Our flagship treatments for hair loss is currently in clinical trials to verify the benefit to patients. Potential partnerships include involvement in clinical trials of our active products or in our earlier stage clinical research in preventing chemotherapy induced infertility and minimising the adverse events associated with vascular access in oncology patients. Participate in our research and bring important benefits to patients and to your practice. 


Hir los
Periphera Neuo

Collaborate in active clinical and pre-clinical research

Active Clinical Trials in Hair Loss

Clinical Need & Technology

47% of patients consider hair loss the most traumatic aspect of treatment. The Lily Device is a portable cap-like device which uses a novel compression therapy approach to mitigate drug delivery to the hair follicles, improving patient comfort and eliminating administrative barriers for providers.

Benefits for Providers

Provide hair loss treatment with no compromises. The Lily Device is portable and patient operated, meaning no extra time per patient in clinic (saving over 90 minutes per visit against competitors), and no storage or administration requirements.

Clinical Research

Active clinical trials in Europe. Currently recruiting centres in the United States.

Active Clinical Trials in Peripheral Neuropathy

Clinical Need & Technology

Up to 68% of all chemotherapy patients experience CIPN during or after their treatment. Luminate's Lilac device aims to be the world's first comfortable, portable and preventative solution to CIPN, enabling physicians to deliver chemotherapy treatment without compromise.

Benefits for Providers

Lilac will aim to reduce incidence and severity of CIPN, reducing cost of follow up to oncology clinics by an estimated $17k per patient. 

Clinical Research

Proof of concept development ongoing. Identifying suitable research partners in the United States and Europe.

Join our clinical research in fertility, menopause, and vascular access

We're continuing to invest in tackling new needs in cancer care, with research focus areas in fertility preservation, early onset menopause, and improving vascular access for oncology patients. Contact us to get involved with pre-clinical and clinical trials in these areas.

Lily in Chair_edited.jpg
Lily Phone_edited.jpg
Clinial Research

Participate in our clinical research

We're delighted to partner with leading physicians and researchers around the world in our mission to enable patients to take control of cancer treatment. Join our clinical research network and you can play a key role in developing new technology to help cancer patients everywhere.

Submission successful.

Anchor 1
bottom of page